
ENOB P/E Ratio
P/E Ratio as of Dec 17, 2025: -0.12
Average-0.1536
Median-0.1600
Minimum-0.1900
Maximum-0.1200
-0.12
0.01 (7.69%)past month
The P/E ratio for ENOB is -0.12 as of Dec 17, 2025. This represents a decrease of -75.51% compared to its 12-month average P/E ratio of -0.49. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Enochian Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Enochian Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Enochian Biosciences Inc to industry peers.
Enochian Biosciences Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Enochian Biosciences Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Enochian Biosciences Inc to industry peers.
ENOB P/E Ratio Insights
See Enochian Biosciences Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ENOB
Order type
Buy in
Order amount
Est. shares
0 shares
ENOB P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $1.31 | -0.17 |
| Nov 3, 2025 | $0.8709 | -0.08 |
| Oct 1, 2025 | $1.28 | -0.13 |
| Sep 2, 2025 | $2.275 | -0.21 |
| Aug 1, 2025 | $2.585 | -0.24 |
| Jul 1, 2025 | $2.72 | -0.25 |
| Jun 2, 2025 | $2.899 | -0.62 |
| May 1, 2025 | $3.095 | -0.66 |
| Apr 1, 2025 | $5.006 | -1.07 |
| Mar 3, 2025 | $8.937 | -0.89 |
| Feb 3, 2025 | $7.633 | -0.76 |
| Jan 2, 2025 | $7.631 | -0.76 |
ENOB End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.12 | -85.54% |
| 2024 | -0.83 | -82.60% |
| 2023 | -4.77 | +873.47% |
| 2022 | -0.49 | -95.00% |
| 2021 | -9.80 | -21.91% |
| 2020 | -12.55 | — |
FAQs About Enochian Biosciences Inc (ENOB) P/E ratio
The latest P/E ratio of ENOB is -0.12, as of Dec 17, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Enochian Biosciences Inc’s last 12-month average P/E ratio is -0.49, compared to its current P/E ratio of -0.12. This reflects a decrease of -75.51%.
Enochian Biosciences Inc’s current P/E ratio of -0.12 is lower than its last 12-month average P/E of -0.49. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Enochian Biosciences Inc’s average P/E ratio over the last 3 years is -1.59. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Enochian Biosciences Inc’s average P/E ratio over the last 5 years is -4.54. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.